Viral Hepatitis and Co-infection with HIV, 6 – 7 October 2016, Bucharest, Romania

Viral Hepatitis and Co-infection with HIV, 6 – 7 October 2016, Bucharest, Romania
FREE REGISTRATION for members  of Society of Infectious disease and AIDS

2nd Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV

6 – 7 October 2016, Bucharest, Romania

Over the last few years, the field of viral hepatitis and co-infection has undergone several major changes. Therapeutic options are increasing and new data are becoming available incessantly which makes it challenging for healthcare professionals to stay informed and provide the best treatment possible for their patients. Also regional and local situations vary strongly and have a big impact on the decision-making process of the clinician. The Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV has been developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries. Advances in the treatment of viral Hepatitis and HIV are continuing at a rapid and exciting pace, presented and discussed at many large international conferences. Key challenges in the treatment of Hepatitis B and C as well as HIV are specific for this region and need to be discussed among clinicians and scientists from these countries. This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV. Much time will be allocated to discussions and Q&A sessions in order to stimulate interaction and dialogue.   WHO SHOULD ATTEND? Healthcare professionals involved in daily care for HCV patients such as infectious disease doctors, gastro-enterologists, hepatologists; public health specialists; policy makers.  

WHY SHOULD YOU ATTEND?

  • This independent program is developed by regional and international Key Opinion Leaders for the medical and scientific community in Eastern and Central European countries;
  • This meeting aims to provide a unique and much needed platform for scientific and medical interchange and education on treatment of Viral Hepatitis and Co-infection with HIV;
  • It is a focused meeting to address regional challenges and to build collaborations in order to advance the field.

ABSTRACT SUBMISSION

We encourage you to submit abstracts under one or more of the following categories:

  • Treatment issues — Hepatitis-HIV  co-infection
  • Drug Interactions — HIV/Hepatitis agents
  • Hepatitis and HIV monitoring and diagnostic tools
  • Viral Hepatitis Drug Resistance
  • New HCV and HIV antiretroviral agents
  • Liver cancer
  • Liver transplantation
  • Liver Steatosis

We would like to thank all those who contributed to the very successful first edition of the Central and Eastern European Meeting on Viral Hepatitis and Co-infection with HIV, held on 22 – 23 June 2015 in Warsaw, Poland.

The meeting proceedings, including video recordings, can be found on
www.infectiousdiseasesonline.com

Young investigators and authors of accepted abstracts will be offered complimentary registration!

We look forward to seeing you in Bucharest, Paris of the East!

On behalf of the Organizing Committee,

 
Prof. Juergen Rockstroh, MD
University of Bonn
Bonn, Germany
 
Prof. Adrian Streinu – Cercel, MD,  PhD
National Institute for Infectious Diseases “Prof. Dr. Matei Balș”
Bucharest, Romania
 
Jonathan Schapiro, MD
Sheba Medical Center
Tel Aviv, Israel

  To meeting website>>>   Local Organizing Committee Anca Streinu – Cercel, MD, PhD – National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Romania (chair) Cristina Popescu, MD, PhD – National Institute for Infectious Diseases “Prof. Dr. Matei Balș”, Romania Scientific Commitee Krasimir Antonov, MD, PhD – ”St.Ivan Rilski” University Hospital, Sofia, Bulgaria Dénes Bánhegyi, MD –  National Institute for Health Promotion, Budapest, Hungary Saulius Čaplinskas, MD, PhD – Centre for Communicable Diseases and AIDS, Vilnius, Lithuania Marine Gogia, MD – Georgian Harm Reduction Network, Tbilisi, Georgia Peter Jarčuška, MD, PhD – PJ Šafárik University, Košice, Slovakia Brygida Knysz, MD, PhD – Medical University of Wroclaw, Wroclaw, Poland Mojca Matičič, MD, PhD – University Medical Centre, Ljubljana, Slovenia Milosz Parczewski, MD, PhD – Pomeranian Medical University in Szczecin, Szczecin, Poland Dalibor Sedláček, MD, PhD – University Hospital of Pilzen, Pilzen, Czech Republic Tengiz Tsertsvadze, MD, PhD – AIDS and Clinical Immunology Research Center, Tbilisi, Georgia